首页 > 最新文献

Journal of Virus Eradication最新文献

英文 中文
Bypassing primary antiretroviral therapy centres in Sub-Saharan Africa: An integrative review of the theoretical and empirical literature 绕过初级抗逆转录病毒治疗中心在撒哈拉以南非洲:理论和实证文献的综合审查。
IF 3.5 4区 医学 Q2 IMMUNOLOGY Pub Date : 2024-12-01 DOI: 10.1016/j.jve.2024.100580
Maximillian Kolbe Domapielle , Sadat Zakari Abugbila , Marshall Kala
The uptake of antiretroviral therapy (ART) is critical to meeting the global HIV treatment goal of 95-95-95 by 2025. Although a few Sub-Saharan African countries have already achieved this target, the prevalence of bypassing primary ART centres in many countries in the subregion has negative implications for ART uptake and use. This study used the access to health services framework to analyse the evidence and factors contributing to bypassing primary ART centres by individuals in the sub-region seeking HIV care and support. We found compelling evidence of the prevalence of ART clients bypassing their primary ART centres in search of specialised care in higher-tiered health facilities. Others use bypassing to conceal their HIV-positive status to avoid social stigma. We argue that introducing specialised and differentiated ART at the primary level of care can address this phenomenon. While we anticipate that this measure will satisfy clients' desire for specialised care, we recommend enhancing public awareness about the effectiveness of ART to reduce stigma towards ART clients. Legislation and strict enforcement of anti-HIV stigma laws, which outlaw and criminalise stigmatising people living with HIV (PLHIV), could potentially be an effective stigma-deterring measure. To complement this effort, PLHIV should be empowered to understand legislative instruments and steps to take when confidentiality and discriminatory issues arise. We recommend further research in Sub-Saharan Africa to investigate the relationship between bypassing primary ART centres and client adherence. The findings will help design appropriate strategies to increase ART uptake at primary ART centres.
接受抗逆转录病毒治疗对于实现到2025年95-95-95全球艾滋病毒治疗目标至关重要。尽管少数撒哈拉以南非洲国家已经实现了这一目标,但该分区域许多国家绕过初级抗逆转录病毒治疗中心的普遍现象对抗逆转录病毒治疗的接受和使用产生了负面影响。本研究使用获得卫生服务框架来分析导致该次区域寻求艾滋病毒护理和支持的个人绕过初级抗逆转录病毒治疗中心的证据和因素。我们发现了令人信服的证据,表明抗逆转录病毒治疗患者普遍绕过其初级抗逆转录病毒治疗中心,在更高级的卫生设施中寻求专业护理。另一些人则通过回避来隐瞒自己的艾滋病毒阳性状况,以避免社会污名。我们认为,在初级保健阶段引入专业化和差异化的抗逆转录病毒治疗可以解决这一现象。虽然我们预计这一措施将满足客户对专业护理的愿望,但我们建议提高公众对抗逆转录病毒治疗有效性的认识,以减少对抗逆转录病毒治疗客户的污名。立法和严格执行反艾滋病毒污名法,将污名化艾滋病毒感染者(PLHIV)定为非法和刑事犯罪,可能是一种有效的阻止污名化的措施。为了补充这一努力,应赋予艾滋病毒感染者了解法律文书和在出现保密和歧视问题时应采取的步骤的权力。我们建议在撒哈拉以南非洲开展进一步研究,以调查绕过初级抗逆转录病毒治疗中心与患者依从性之间的关系。研究结果将有助于制定适当的战略,以增加初级抗逆转录病毒治疗中心对抗逆转录病毒治疗的接受。
{"title":"Bypassing primary antiretroviral therapy centres in Sub-Saharan Africa: An integrative review of the theoretical and empirical literature","authors":"Maximillian Kolbe Domapielle ,&nbsp;Sadat Zakari Abugbila ,&nbsp;Marshall Kala","doi":"10.1016/j.jve.2024.100580","DOIUrl":"10.1016/j.jve.2024.100580","url":null,"abstract":"<div><div>The uptake of antiretroviral therapy (ART) is critical to meeting the global HIV treatment goal of 95-95-95 by 2025. Although a few Sub-Saharan African countries have already achieved this target, the prevalence of bypassing primary ART centres in many countries in the subregion has negative implications for ART uptake and use. This study used the access to health services framework to analyse the evidence and factors contributing to bypassing primary ART centres by individuals in the sub-region seeking HIV care and support. We found compelling evidence of the prevalence of ART clients bypassing their primary ART centres in search of specialised care in higher-tiered health facilities. Others use bypassing to conceal their HIV-positive status to avoid social stigma. We argue that introducing specialised and differentiated ART at the primary level of care can address this phenomenon. While we anticipate that this measure will satisfy clients' desire for specialised care, we recommend enhancing public awareness about the effectiveness of ART to reduce stigma towards ART clients. Legislation and strict enforcement of anti-HIV stigma laws, which outlaw and criminalise stigmatising people living with HIV (PLHIV), could potentially be an effective stigma-deterring measure. To complement this effort, PLHIV should be empowered to understand legislative instruments and steps to take when confidentiality and discriminatory issues arise. We recommend further research in Sub-Saharan Africa to investigate the relationship between bypassing primary ART centres and client adherence. The findings will help design appropriate strategies to increase ART uptake at primary ART centres.</div></div>","PeriodicalId":17552,"journal":{"name":"Journal of Virus Eradication","volume":"10 4","pages":"Article 100580"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11751520/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143022971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Disclaimer 免责声明
IF 3.5 4区 医学 Q2 IMMUNOLOGY Pub Date : 2024-12-01 DOI: 10.1016/j.jve.2024.100545
{"title":"Disclaimer","authors":"","doi":"10.1016/j.jve.2024.100545","DOIUrl":"10.1016/j.jve.2024.100545","url":null,"abstract":"","PeriodicalId":17552,"journal":{"name":"Journal of Virus Eradication","volume":"10 ","pages":"Page iv"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143180789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
1.6 – 00161 HIV-1 Antisense Transcripts are frequent in FOXP3-negative Treglike cells expressing markers of persistence in vivo during acute HIV- 1 infection HIV-1反义转录物在foxp3阴性的Treglike细胞中很常见,在急性HIV-1感染期间表达体内持久性标记物
IF 3.5 4区 医学 Q2 IMMUNOLOGY Pub Date : 2024-12-01 DOI: 10.1016/j.jve.2024.100399
M. Hale, G. Kundu, A. Geretz, P. Ehrenberg, R. Clifford, M. Robb, C. Sacdalan, S. Sriplienchan, N. Phanuphak, S. Vasan, R. Thomas, RV254 study team
{"title":"1.6 – 00161 HIV-1 Antisense Transcripts are frequent in FOXP3-negative Treglike cells expressing markers of persistence in vivo during acute HIV- 1 infection","authors":"M. Hale,&nbsp;G. Kundu,&nbsp;A. Geretz,&nbsp;P. Ehrenberg,&nbsp;R. Clifford,&nbsp;M. Robb,&nbsp;C. Sacdalan,&nbsp;S. Sriplienchan,&nbsp;N. Phanuphak,&nbsp;S. Vasan,&nbsp;R. Thomas,&nbsp;RV254 study team","doi":"10.1016/j.jve.2024.100399","DOIUrl":"10.1016/j.jve.2024.100399","url":null,"abstract":"","PeriodicalId":17552,"journal":{"name":"Journal of Virus Eradication","volume":"10 ","pages":"Page 4"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143176157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ST2.1 – 00087 A Novel HIV-1 Immune Evasion Strategy: How Softer HIV-1 Infected cells Preferentially Resist Cytotoxic T Lymphocytes (CTLs) 一种新的HIV-1免疫逃避策略:较软的HIV-1感染细胞如何优先抵抗细胞毒性T淋巴细胞(ctl)
IF 3.5 4区 医学 Q2 IMMUNOLOGY Pub Date : 2024-12-01 DOI: 10.1016/j.jve.2024.100446
L. Leyre, F. Mustapha, A. Herrera, M. Huse, R.B. Jones
{"title":"ST2.1 – 00087 A Novel HIV-1 Immune Evasion Strategy: How Softer HIV-1 Infected cells Preferentially Resist Cytotoxic T Lymphocytes (CTLs)","authors":"L. Leyre,&nbsp;F. Mustapha,&nbsp;A. Herrera,&nbsp;M. Huse,&nbsp;R.B. Jones","doi":"10.1016/j.jve.2024.100446","DOIUrl":"10.1016/j.jve.2024.100446","url":null,"abstract":"","PeriodicalId":17552,"journal":{"name":"Journal of Virus Eradication","volume":"10 ","pages":"Pages 35-36"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143181216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Table of content 目录表
IF 3.5 4区 医学 Q2 IMMUNOLOGY Pub Date : 2024-12-01 DOI: 10.1016/j.jve.2024.100546
{"title":"Table of content","authors":"","doi":"10.1016/j.jve.2024.100546","DOIUrl":"10.1016/j.jve.2024.100546","url":null,"abstract":"","PeriodicalId":17552,"journal":{"name":"Journal of Virus Eradication","volume":"10 ","pages":"Page v"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143180788","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
3.3 – 00093 RasGRP1 agonists induce cyclin T1 translation to reverse HIV-1 latency in primary CD4+ T cells 3.3 - 00093 RasGRP1 激动剂诱导细胞周期蛋白 T1 翻译,逆转原代 CD4+ T 细胞中的 HIV-1 潜伏期
IF 3.5 4区 医学 Q2 IMMUNOLOGY Pub Date : 2024-12-01 DOI: 10.1016/j.jve.2024.100408
U. Mbonye, A. Bellomo, E. Elhalem, L. Gandolfi Donadio, M. Julieta Comin, J. Karn
{"title":"3.3 – 00093 RasGRP1 agonists induce cyclin T1 translation to reverse HIV-1 latency in primary CD4+ T cells","authors":"U. Mbonye,&nbsp;A. Bellomo,&nbsp;E. Elhalem,&nbsp;L. Gandolfi Donadio,&nbsp;M. Julieta Comin,&nbsp;J. Karn","doi":"10.1016/j.jve.2024.100408","DOIUrl":"10.1016/j.jve.2024.100408","url":null,"abstract":"","PeriodicalId":17552,"journal":{"name":"Journal of Virus Eradication","volume":"10 ","pages":"Pages 9-10"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143181917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
6.5 – 00173 A single-infusion of CCR5 modified stem-like CD4 T cells to limit HIV/SIV persistence during ART and promote control of viremia upon ATI 单次输注CCR5修饰的干细胞样CD4 T细胞限制抗逆转录病毒治疗期间HIV/SIV的持续存在并促进ATI后病毒血症的控制
IF 3.5 4区 医学 Q2 IMMUNOLOGY Pub Date : 2024-12-01 DOI: 10.1016/j.jve.2024.100428
A.A. Sharma, J. Zeidan, M. Islam, J. Harper, A.B. Enriquez, G. Lee, K. Nguyen, J. Auger, H. Flores, R. Fromentin, G.P. Sanchez, J.L.C. De Azeved, F.A. Procopio, R. Balderas, J.P. Lalezari, N. Chomont, D. Ando, A. Wilkes, R. Stammen, M. Paiardini, R.P. Sekaly
{"title":"6.5 – 00173 A single-infusion of CCR5 modified stem-like CD4 T cells to limit HIV/SIV persistence during ART and promote control of viremia upon ATI","authors":"A.A. Sharma,&nbsp;J. Zeidan,&nbsp;M. Islam,&nbsp;J. Harper,&nbsp;A.B. Enriquez,&nbsp;G. Lee,&nbsp;K. Nguyen,&nbsp;J. Auger,&nbsp;H. Flores,&nbsp;R. Fromentin,&nbsp;G.P. Sanchez,&nbsp;J.L.C. De Azeved,&nbsp;F.A. Procopio,&nbsp;R. Balderas,&nbsp;J.P. Lalezari,&nbsp;N. Chomont,&nbsp;D. Ando,&nbsp;A. Wilkes,&nbsp;R. Stammen,&nbsp;M. Paiardini,&nbsp;R.P. Sekaly","doi":"10.1016/j.jve.2024.100428","DOIUrl":"10.1016/j.jve.2024.100428","url":null,"abstract":"","PeriodicalId":17552,"journal":{"name":"Journal of Virus Eradication","volume":"10 ","pages":"Page 23"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143128875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2.6 – 00158 Doubling dolutegravir dosage reduces the viral reservoir in ARTtreated people with HIV 2.6 - 00158加倍多替格拉韦剂量可减少接受art治疗的艾滋病毒感染者的病毒库
IF 3.5 4区 医学 Q2 IMMUNOLOGY Pub Date : 2024-12-01 DOI: 10.1016/j.jve.2024.100405
A. Pasternak, C. Fombellida-Lopez, A. Cicilionytė, L. Winchester, M. Maes, P. Dellot, C. Vanwinge, A. Ladang, E. Cavalier, F. Susin, D. Vaira, M.P. Hayette, C. Reenaers, M. Moutschen, C. Fletcher, G. Darcis
{"title":"2.6 – 00158 Doubling dolutegravir dosage reduces the viral reservoir in ARTtreated people with HIV","authors":"A. Pasternak,&nbsp;C. Fombellida-Lopez,&nbsp;A. Cicilionytė,&nbsp;L. Winchester,&nbsp;M. Maes,&nbsp;P. Dellot,&nbsp;C. Vanwinge,&nbsp;A. Ladang,&nbsp;E. Cavalier,&nbsp;F. Susin,&nbsp;D. Vaira,&nbsp;M.P. Hayette,&nbsp;C. Reenaers,&nbsp;M. Moutschen,&nbsp;C. Fletcher,&nbsp;G. Darcis","doi":"10.1016/j.jve.2024.100405","DOIUrl":"10.1016/j.jve.2024.100405","url":null,"abstract":"","PeriodicalId":17552,"journal":{"name":"Journal of Virus Eradication","volume":"10 ","pages":"Pages 7-8"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143128931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
4.6 – 00114 Transcriptomic profile of gut T follicular helper cells during persistent HIV infection 持续HIV感染期间肠道T滤泡辅助细胞的转录组学特征
IF 3.5 4区 医学 Q2 IMMUNOLOGY Pub Date : 2024-12-01 DOI: 10.1016/j.jve.2024.100417
F. Cossarini, A. Krek, D. D’souza, Z. Chen, S. Kim-Schulze, B.K. Chen, F. Petralia, S. Mehandru
{"title":"4.6 – 00114 Transcriptomic profile of gut T follicular helper cells during persistent HIV infection","authors":"F. Cossarini,&nbsp;A. Krek,&nbsp;D. D’souza,&nbsp;Z. Chen,&nbsp;S. Kim-Schulze,&nbsp;B.K. Chen,&nbsp;F. Petralia,&nbsp;S. Mehandru","doi":"10.1016/j.jve.2024.100417","DOIUrl":"10.1016/j.jve.2024.100417","url":null,"abstract":"","PeriodicalId":17552,"journal":{"name":"Journal of Virus Eradication","volume":"10 ","pages":"Page 16"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143139364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fixation and reversion of mutations in the receptor-binding domain of the SARS-CoV-2 spike protein: A 2020–2024 analysis SARS-CoV-2刺突蛋白受体结合域突变的固定和逆转:2020-2024年分析
IF 3.5 4区 医学 Q2 IMMUNOLOGY Pub Date : 2024-12-01 DOI: 10.1016/j.jve.2024.100581
Daniele Focosi , Pietro Giorgio Spezia , Fabrizio Maggi
{"title":"Fixation and reversion of mutations in the receptor-binding domain of the SARS-CoV-2 spike protein: A 2020–2024 analysis","authors":"Daniele Focosi ,&nbsp;Pietro Giorgio Spezia ,&nbsp;Fabrizio Maggi","doi":"10.1016/j.jve.2024.100581","DOIUrl":"10.1016/j.jve.2024.100581","url":null,"abstract":"","PeriodicalId":17552,"journal":{"name":"Journal of Virus Eradication","volume":"10 4","pages":"Article 100581"},"PeriodicalIF":3.5,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11755027/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143029035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Virus Eradication
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1